Saint-Germain Pharma Ltd
10218474
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 01/10/2025
DIRECTOR
BRITISH · ENGLAND · Age 40
Also on 12 other boards
director · Since 01/10/2025
DIRECTOR
BRITISH · ENGLAND · Age 49
Also on 10 other boards
director · Since 01/10/2025
DIRECTOR
BRITISH · ENGLAND · Age 56
Also on 12 other boards
Persons with Significant Control
Aspire Pharma Limited
102, High Street, Godalming, GU7 1DS
Reg: 06828501 · Companies House · Private Limited Company
Notified 01/10/2025
Former PSCs
Present Value Limited
Ceased 01/10/2025
CompanyRankvs 3660+ SIC 46460 peers73
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£305k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£305k
Working capital
Current Assets
£468k
Current Liabilities
£163k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.87 | +£294k |
| 2024 | 1.07 | +£130k |
| 2023 | 0.12 | -£40k |
| 2022 | 0.09 | -£54k |
| 2021 | 0.00 | — |
Derived from filed accounts. Not audited figures.